Hepatitis B Virus Vaccine
‘It’s time for action’: World Hepatitis Day calls to end an ‘entirely preventable disease’
Every year on July 28th, clinicians and researchers recognize World Hepatitis Day to bring awareness to one of the world’s deadliest but preventable viruses and continue efforts to meet the global goal of eliminating viral hepatitis by 2030
Adjuvanted hepatitis B vaccine effective among nonresponsive HCWs
A two-dose series of a hepatitis B vaccine with a CpG adjuvant resulted in a more than 90% response rate among health care workers previously classified as nonresponders, researchers found.
HBV vaccine nonresponders should be considered for revaccination after HCV cure
People who were not responsive to hepatitis B vaccination should be considered for revaccination following hepatitis C cure, researchers reported.
Q&A: Hepatitis D screening, prevention in primary care
Healio spoke with John D. Scott, MD, MSc, FIDSA, chief digital health officer at UW Medicine, professor of allergy and infectious diseases at University of Washington and medical director at the Liver Clinic at Harborview Medical Center, to learn more about what PCPs can do to help prevent and screen for HDV.
Few PCPs implementing universal HBV vaccination guidance
It is finally possible to eliminate hepatitis B virus in the United States, as long as a multipronged strategy is used to fully implement new guidance that recommends universal vaccination for adults aged 19 to 59 years, experts said.
TDF, postnatal immunization prevent vertical transmission of HBV
Researchers said the most effective approach to preventing vertical transmission of hepatitis B virus was a combination of maternal use of tenofovir disoproxil fumarate, or TDF, and postnatal immunization.
Top in ID: US responds to Omicron variant, FDA approves novel HBV vaccine
Information related to the new omicron variant, including the United States’ response to it and details of its first case in the U.S, made up most of the top stories in infectious disease last week.
Top in ID: COVID-19 surge ‘inevitable,’ antiviral shows promise
Former CDC Director Tom Frieden, MD, MPH, said that a surge in COVID-19 cases is “inevitable” due to low vaccination rates in the United States.
USPSTF publishes HBV recommendation amid declines in screening, vaccination
The United States Preventive Services Task Force recently published a new statement strengthening its 2014 recommendation to screen for hepatitis B virus in adolescents and adults who are at an increased risk for infection.
Positive interim results observed in ongoing study of HBV vaccine
VBI Vaccines Inc. announced positive interim clinical results from an ongoing phase 1b/2a study of VBI-2601 (BRII-179), a novel recombinant, protein-based immunotherapeutic candidate for the treatment of chronic hepatitis B infection.